# BASF SE - Inspection Records

Source: https://www.keypedia.com/companies/basf-se/96b65069-a37b-4a26-9655-5f310b60cc6f

> Inspection records and compliance data for BASF SE in Rhineland-Palatinate, None. Access full analysis and detailed observations.

---

## Details

- Name: BASF SE
- FEI Number: 3002903906
- City: Rhineland-Palatinate
- State: None
- Country Name: Germany
- Address Line 1: Carl-Bosch-Str. 38
- Address Line 2: Ludwigshafen Am Rhein
- Zip Code: None
- Business Operations: API MANUFACTURE

## Related Documents

- [FDA Inspection 1289396 - BASF SE - 2024-08-29](https://www.keypedia.com/records/fda_inspections/basf-se/64951c7e-0e1a-44ec-aa4c-79cf266155c8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 29, 2024
- [FDA Inspection 1220597 - BASF SE - 2020-09-16](https://www.keypedia.com/records/fda_inspections/basf-se/ed964394-28e2-40d4-9300-d384c9e7d5c1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 16, 2020
- [EIR - BASF SE - 2018-07-13](https://www.keypedia.com/records/eir/basf-se/27087d27-999a-4777-9750-163ec739a1a1) — source: FDA, date: July 13, 2018
- [EIR - BASF SE - 2018-07-13](https://www.keypedia.com/records/eir/basf-se/7dd33db3-3652-4440-894b-b6cd6f7d530c) — source: FDA, date: July 13, 2018
- [FDA Inspection 1061372 - BASF SE - 2018-07-13](https://www.keypedia.com/records/fda_inspections/basf-se/0fb45418-9d06-4ec4-8222-3bdb900249a7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 13, 2018
- [EIR - BASF SE - 2016-03-10](https://www.keypedia.com/records/eir/basf-se/7a679d34-3064-422a-a80d-92783d966800) — source: FDA, date: March 10, 2016
- [FDA Inspection 989833 - BASF SE - 2016-03-10](https://www.keypedia.com/records/fda_inspections/basf-se/e8bef12f-25a4-49bc-b062-9c7ed1e7d40e) — classification: No Action Indicated (NAI), source: FDA, date: March 10, 2016
- [EIR - BASF SE - 2013-07-30](https://www.keypedia.com/records/eir/basf-se/57e1a517-1e11-4748-9af8-82b93854b791) — source: FDA, date: July 30, 2013
- [FDA Inspection 841539 - BASF SE - 2013-06-27](https://www.keypedia.com/records/fda_inspections/basf-se/9aa73a23-b721-4118-ab97-2c9fe1813693) — classification: No Action Indicated (NAI), source: FDA, date: June 27, 2013
- [EIR - BASF SE - 2010-03-17](https://www.keypedia.com/records/eir/basf-se/c5f29c33-7620-43c4-8738-516f12311f28) — source: FDA, date: March 17, 2010
- [FDA Inspection 659697 - BASF SE - 2010-03-17](https://www.keypedia.com/records/fda_inspections/basf-se/a922d38f-9219-4979-abf8-679f9c9f3556) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 17, 2010

## Related Companies

- [Hetero Labs Ltd. - Unit IX](https://www.keypedia.com/companies/hetero-labs-ltd-unit-ix/b44e59b6-5413-4ef1-83a3-411f3684bdc3)
- [Sionc Pharmaceuticals Private Limited](https://www.keypedia.com/companies/sionc-pharmaceuticals-private-limited/24c737f1-e449-4957-ad35-1990c5d68e2d)
- [Fresenius Kabi Oncology Ltd](https://www.keypedia.com/companies/fresenius-kabi-oncology-ltd/c145255a-d691-4f05-8873-bf1e09b6aa97)
- [Tokyo Chemical Industry Co Ltd](https://www.keypedia.com/companies/tokyo-chemical-industry-co-ltd/777f1c4a-29f8-48cc-9a51-dc89b896f327)
- [Unilab Chemicals and Pharmaceuticals Private Ltd.](https://www.keypedia.com/companies/unilab-chemicals-and-pharmaceuticals-private-ltd/4527d913-752e-4f0a-b281-5ec30695ede9)
- [BioChem Sioux City Inc.](https://www.keypedia.com/companies/biochem-sioux-city-inc/5ce2b95e-6c89-4fb9-bbb4-210bd8272365)
- [Minteq UK Limited](https://www.keypedia.com/companies/minteq-uk-limited/08f82870-b388-4939-8b90-729be4cd9154)
- [SI Group, Inc.](https://www.keypedia.com/companies/si-group-inc/6f15e9d4-610c-474c-907b-9d9d3b5621f3)
- [Valens Molecules Private Limited](https://www.keypedia.com/companies/valens-molecules-private-limited/782b14d8-72b3-4782-9a8c-fdf4373bee0b)
- [Les Produits Chimiques B.G.R., Inc.](https://www.keypedia.com/companies/les-produits-chimiques-bgr-inc/348f9540-7743-4466-b340-676434a19914)

## Related Officers

- [investigator](https://www.keypedia.com/people/james-c-maclaughlin/b4a44fd7-c09a-4f4c-bc39-5c254dfa468c)
- [issuing_officer](https://www.keypedia.com/people/mel-szymanski/26407a5b-9c09-428a-8e28-3efc1ec2e655)
- [other](https://www.keypedia.com/people/elizabeth-philpy/1c92e21e-f7bf-4737-b8da-02ee24b16480)
- [other](https://www.keypedia.com/people/l-daurio/f5bcc1bf-0159-4506-a1f6-1ecf0f97527d)
- [recipient](https://www.keypedia.com/people/rainer-fendt/3d6b1658-da6b-48cb-8ffb-ef0ab2aea47c)
- [FDA Alumnus, Principal at ESCODA Consulting Group, and Scientific Advisory Board Member at AiZen Algo](https://www.keypedia.com/people/concepcion-cruz/831264a6-1a6b-47f1-b0bf-f3091d3b2f1c)